BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biologix Corporation


Contact Details:
4th Fl. Korea Polymer Bldg. 807-3 Bang-bae-dong Seocho-Gu
Seoul
Seoul
137-060
South Korea
Tel:822 3482 9500
Fax:822 537 3450
Email:

Recent Publications by Biologix Corporation:

A pan-HER approach for cancer therapy: background, current status and future development.
BACKGROUND: The human EGF receptor (EGFR or HER) family and its cognate...
10th December, 2008
Receptor BioLogix, Inc., Palo Alto, CA 94303, USA. Expert Opin Biol Ther. 2009 Jan;9(1):97-110.
DOI Direct Link
Rational Optimization of a Bispecific Ligand Trap Targeting EGF Receptor Family Ligands.
The human EGF receptor (HER) family members cooperate in malignancy. Of...
3rd December, 2008
Receptor BioLogix, Inc., Palo Alto, California, USA. Mol Med. 2008 Nov 23.
DOI Direct Link
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts.
All four members of the human epidermal growth factor (EGF) receptor (HER)...
13th November, 2008
Receptor BioLogix, Inc., 3350 West Bayshore Road, Suite 150, Palo Alto, CA Mol Cancer Ther. 2008 Oct;7(10):3223-36.
DOI Direct Link
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.
The human EGFR (HER) family is essential for communication between many...
5th November, 2008
Receptor BioLogix, Inc., J Clin Invest. 2008 Nov;118(11):3574-81.
DOI Direct Link
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.
INTRODUCTION: Despite the advent of biological therapies for the treatment...
3rd July, 2008
Receptor BioLogix, Arthritis Res Ther. 2008;10(4):R73. Epub 2008 Jul 1.
DOI Direct Link

View more Biologix Corporation research publications.

BioNews Results for Biologix Corporation:

Florida Biologix Continues To Build Strong Filling Track Record With 3 Contracts Signed In 3rd Quarter
Bioresearch Online:  Dec 11 2008 8:17PM Matching: biologix
Receptor BioLogix Relaunches with New CEO and New Focus
Pharma Live:  Oct 28 2008 7:46PM Matching: biologix
Newly Published Preclinical Study Shows Receptor BioLogix's Pan-HER Ligand Trap Has Broad Anti-Cancer Activity
Pharma Live:  Oct 28 2008 3:53PM Matching: biologix
Expansion Sees Q Chip Move to New Facility
BioPortfolio:  Oct 23 2008 4:48PM Matching: biologix
BioPartnering Europe (BPE) Continues to Stand Out as Europe's Premier Biotech Partnering Conference
Business Wire via Yahoo!:  Oct 23 2008 9:43AM Matching: biologix
Promote your company here: BioNewsCast - Press Release Distribution

View more Biologix Corporation news.

Biologix Corporation Patents:

US Patent No.Title
7235376 Gastrin hormone immunoassays
4940945 Interface circuit for use in a portable blood chemistry measuring apparatus
5766669 Sintering process for producing thin films of calcium phosphate entities
5849569 Assessment of bone cell activity
5861306 Multi-well bone culture device for use in assessment of bone cell activity

View more Biologix Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 190 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: biologix res | t | millenium biologix and herceptin | .

Search for more companies in Seoul

Search for more companies in Seoul



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biologix Corporation

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.